Sanofi and Regeneron's Dupixent gets more positive feedback from U.S. FDA - companies

The U.S. Food & Drug Administration (FDA) regulator gave more positive feedback on the Dupixent eczema treatment being developed by drugmakers Sanofi and Regeneron, the companies said on Tuesday.

from Reuters: Company News https://ift.tt/2DnlWRL
via IFTTT